Worth reading
40Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
127400
¥ per stock acquisition rightWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of Stock Options (Stock Acquisition Rights) to Directors, Executive Officers and Employees
Who receives how much
15,710 stock acquisition rights (100 shares per stock acquisition right)
4 directors of the Company (excluding outside directors)1,880 stock acquisition rights (188,000 shares)
Company executive officers (excluding those concurrently serving as directors), 13 people2,275 stock acquisition rights (227,500 shares)
116 employees of the company11,555 stock acquisition rights (1,155,500 shares)
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
¥127,400 per stock acquisition right (¥1,274 per share)
Amount of funds to be raised
Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed (offset against cash compensation equivalent to the payment amount)
Total Stock-Based Compensation
Cash compensation equivalent to the total payment amount for the stock acquisition rights to be allocated: Not disclosed
Terms of the stock acquisition rights
Exercise period
From 1 October 2028 to 29 September 2033
Number of Stock Acquisition Rights
Total issued: 15,710 stock acquisition rights; outstanding and unexercised: Not disclosed
Categories and Number of Persons Covered
Company directors (excluding outside directors), 4 people: 1,880 stock acquisition rights, Company executive officers (excluding those concurrently serving as directors), 13 people: 2,275 stock acquisition rights, Company employees, 116 people: 11,555 stock acquisition rights
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Stock Options (Stock Acquisition Rights) to Directors, Executive Officers and Employees |
| Number of shares to be issued or disposed of | 15,710 stock acquisition rights (100 shares per stock acquisition right) |
| Issue price and disposal price | ¥127,400 per stock acquisition right (¥1,274 per share) |
| Amount of funds to be raised | Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed (offset against cash compensation equivalent to the payment amount) |
| Intended allottee | Name 4 directors of the Company (excluding outside directors) / Number of Shares 1,880 stock acquisition rights (188,000 shares), Name Company executive officers (excluding those concurrently serving as directors), 13 people / Number of Shares 2,275 stock acquisition rights (227,500 shares), Name 116 employees of the company / Number of Shares 11,555 stock acquisition rights (1,155,500 shares) |
| Exercise period | From 1 October 2028 to 29 September 2033 |
| Number of Stock Acquisition Rights | Total issued: 15,710 stock acquisition rights; outstanding and unexercised: Not disclosed |
| Categories and Number of Persons Covered | Company directors (excluding outside directors), 4 people: 1,880 stock acquisition rights, Company executive officers (excluding those concurrently serving as directors), 13 people: 2,275 stock acquisition rights, Company employees, 116 people: 11,555 stock acquisition rights |
| Total Stock-Based Compensation | Cash compensation equivalent to the total payment amount for the stock acquisition rights to be allocated: Not disclosed |
Items this document does not state (19)
Total issue valueEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The payment amount for the stock options approved on 15 September 2026 was finalized. The eligible recipients will receive cash compensation equivalent to the payment amount, and the compensation receivable will be offset against their payment obligation.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.